If opioids are indicated and clinically appropriate for prescription for acute pain, prescribing licensees shall:
- (a) Conduct and document an examination of the oral cavity and associated structures and a medical history;
- (b) Consider the patient’s risk for opioid misuse, abuse, or diversion and prescribe for the lowest effective dose for less than 30 days;
- (c) Document the prescription and rationale for all opioids;
(d) Ensure that the patient has been provided information that contains the following:
- (1) Risk of side effects, including addiction and overdose resulting in death;
- (2) Risks of keeping unused medication;
- (3) Options for safely securing and disposing of unused medication; and
- (4) Danger in operating motor vehicle or heavy machinery;
- (e) Comply with all federal and state controlled substances laws, rules, and regulations;
- (f) Complete a board-approved risk assessment tool, such as the evidence based screening tool Screener and Opioid Assessment for Patients with Pain (SOAPP);
- (g) Document the consideration of non-pharmacological modalities and non-opioid therapy, and an appropriate pain treatment plan which includes the type of drug, the dosage, and the duration of the prescription;
(h) Utilize a written informed consent that explains the following risks associated with opioids:
- (1) Addiction;
- (2) Overdose and death;
- (3) Physical dependence;
- (4) Physical side effects;
- (5) Hyperalgesia;
- (6) Tolerance; and
- (7) Crime victimization;
(i) In an emergency department, urgent care setting, or walk-in clinic:
- (1) Not prescribe more than the minimum amount of opioids dentally necessary to treat the patient’s dental condition. In most cases, an opioid prescription of 3 or fewer days is sufficient, but a licensee shall not prescribe for more than 7 days; and
- (2) If prescribing an opioid for acute pain that exceeds a board-approved limit, document the dental condition and appropriate clinical rationale in the patient’s medical record; and
- (j) Not be obligated to prescribe opioids for more than 30 days, but if opioids are indicated and appropriate for persistent, unresolved acute pain that extends beyond a period of 30 days, the licensee shall work in concert with the patient’s primary care physician or a licensed pain management program, and shall continue to adhere to the terms of Den 503.05 for establishing a pain management program.
Source. #11130, eff 6-29-16; ss by #12061, eff 1-1-17 (from Den 503.03); renumbered by #12167, eff 3-7-25 (formerly Den 503.04)